National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

lapatinib (luh-PA-tih-nib)

 A drug used with another anticancer drug to treat breast cancer that is HER2 positive and has advanced or metastasized (spread to other parts of the body) after treatment with other drugs. Lapatinib is also being studied in the treatment of other types of cancer. It is a type of ErbB-2 and EGFR dual tyrosine kinase inhibitor. Also called GW572016, lapatinib ditosylate, and Tykerb.



Previous Definitions:laparoscopic prostatectomy, laparoscopic surgery, laparoscopic-assisted colectomy, laparoscopy, laparotomy
Next Definitions:lapatinib ditosylate, lappa, large cell carcinoma, large granular lymphocyte, large intestine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov